1 / 18

Rapid detection of resistant Gram- negatives directly from specimens

Rapid detection of resistant Gram- negatives directly from specimens. Dr Gemma Vanstone Royal Free Hampstead NHS Trust. Introduction. Development of methods for the rapid detection of ESBL and AmpC producing organisms Empirical therapy does not cover ESBL/AmpC producing organisms

nowles
Télécharger la présentation

Rapid detection of resistant Gram- negatives directly from specimens

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Rapid detection of resistant Gram- negatives directly from specimens Dr Gemma Vanstone Royal Free Hampstead NHS Trust

  2. Introduction • Development of methods for the rapid detection of ESBL and AmpC producing organisms • Empirical therapy does not cover ESBL/AmpC producing organisms • Delayed treatment of infections caused by ESBL/AmpC producing organisms associated with increased mortality

  3. Multi-resistance • Isolates that have an ESBL/AmpC are often multiresistant with few treatment options • Plasmids often carry genes for resistance to other classes of antibiotics • often no oral options available for minor infections • necessitates use of broad-spectrum carbapenems • Could lead to other resistance mechanisms developing

  4. Laboratory Detection Sample received/flags positive ESBL + 24 h ControlESBL- 72 HOURS Gram negative grows 24 h ID and sens ? ESBL – grow with and without clavulante to confirm 24 h

  5. Major ESBL Types * The definition of ESBLs is sometimes stretched to include Class D β-lactamase mutants that hydrolyse oxyimino-cephalosporins, but they are inhibitor resistant Taken from: Pocket Guide to ESBLs in Resistance. D. Livermore & D. Paterson

  6. Epidemiology of ESBLsCTX-M types • Split into phylogenetic groups • eg CTX-M-1, -2, -8, -9 and -26. • First reported late 1980s (Japan and Germany) • Remained rare for a long time in Europe • 2000: 1st report in UK (CTX-M-9 Single K. oxytoca isolate) • 2001: CTX-M-26 and CTX-M-15 • NOW: THE MOST COMMON ESBL TYPE SEEN IN THE UK

  7. Number of cycles Detection of ESBLs directly from blood cultures • A real-time multiplex PCR that can detect and type blaCTX-M genes has been described (Birkett et al, 2007) • One set of primers that bind to all CTX-M groups • Specific probes for the different groups • Performed on isolates Normalized fluorescence • Can this PCR be performed on blood cultures containing Gram negative rods?

  8. Bacterial DNA Extraction direct from blood cultures • BD GeneOhm StaphSR assay extraction • Rapid • Simple • Automation?

  9. 2 hours Observe GNR in sample (eg Blood culture) Extract DNA and set up PCR 2 hours Run PCR and detect CTX-M DNA in real time Towards a Faster Diagnosis

  10. 1 x 109 cells /ml 1 x 104 cells /ml Fig 1: Detection of CTX-M-9 ESBLs in blood cultures containing control organism at 1 x 109 cells/ml to 1 x 102 cells/ml. The detection limit was 1 x 104 cells/ml ESBL PCR on spiked blood cultures • Control organisms representing the 5 CTX-M groups were spiked into negative blood cultures • Rapid DNA extraction and real-time PCR performed • The PCR was able to detect all groups at a limit of 104 bacteria/ml (Positive blood cultures 107-108 bacteria/ml)

  11. Clinical samples, so far... • 230 positive blood cultures containing Gram negative rods tested by PCR • Phenotypic data: 12/230 shown to contain ESBL • PCR: 11/230 shown to contain ESBL • On further testing – discrepant isolate shown to contain OXA type ESBL • Results are available within 4 hours of the blood culture flagging positive

  12. ESBL PCR – Future work... • Evaluation of other samples/fluids • Detection of other ESBL-types • Currently a negative result doesn’t mean ‘ESBL negative’ • On-going project for SHV/TEM/OXA type ESBLs

  13. AmpC • Infection with AmpC producing organisms is associated with many of the risk factors associated with ESBL infection • Routine methods for detection of AmpC producing organisms are similar to those described for ESBLs

  14. Detection of plasmidic AmpC genes • A conventional PCR that can detect the 6 plasmidic groups of AmpC has previously been described • This PCR had previously been performed on isolates • We wanted to convert this PCR into a real-time format that can be performed directly on samples Perez Perez & Hanson 2002

  15. Real-time AmpC PCR: The story so far... • Probes to distinguish between the AmpC families not described • Initially investigating SybrGreen and HRM as a method to detect and distinguish between the AmpC families. • ACC, CIT and FOX can be easily distinguished • ENT and DHA are more similar in melting temperature

  16. AmpC PCR: Work in progress... • Clinical isolates • Collected 5 CIT producing isolates • Spiked blood cultures • Clinical samples • Detected and AmpC in 2/92 blood cultures • Data so far agrees with phenotypic data.

  17. Future Work • Continuation of ‘work in progress’ • Evaluation of PCR methods on other specimens • Detection of other resistance genes • Non CTX-M type ESBLs • Carbapenemase

  18. Acknowledgements • Dr. Indran Balakrishnan • Dr. Bambos Charalambous • Medical Microbiology Laboratory, Royal Free Hampstead NHS Trust • Project students • Katie Mouskos • Laila Ramzi • Lois Wilkie • Ayse Yorgancioglu • Kit Ying Lam • Belinda Tse • Noam Roth

More Related